Project Description
Dr. Emery looked at the effect of 3-mercatopicolinic acid (3-MDA) as an inhibitor of gluconeogenesis. He attempted to normalize the rate of glycogenesis in the liver in hopes of avoiding cancer cachexia and allowing for more aggressive treatments for